China Resources Eyes $1bn Hong Kong IPO As It Streamlines Ops

The Chinese state-owned manufacturer and distributor China Resources Pharmaceutical Group is planning an up to $1bn IPO in Hong Kong this year, as part of an ongoing restructuring of its large diversified business and integration of assets.